Leung M, Swanton C, McGranahan N
Nat Rev Genet. 2025; .
PMID: 40065153
DOI: 10.1038/s41576-025-00825-2.
Li Y, Liu F, Cai Q, Deng L, OuYang Q, Zhang X
Signal Transduct Target Ther. 2025; 10(1):57.
PMID: 39979279
PMC: 11842613.
DOI: 10.1038/s41392-025-02148-4.
Saez-Carrion E, Aguilar-Aragon M, Garcia-Lopez L, Dominguez M, Uribe M
Cells. 2024; 13(23).
PMID: 39682725
PMC: 11640731.
DOI: 10.3390/cells13231977.
Mei W, Faraj Tabrizi S, Godina C, Lovisa A, Isaksson K, Jernstrom H
Cell. 2024; 188(2):371-389.e28.
PMID: 39657676
PMC: 11770377.
DOI: 10.1016/j.cell.2024.11.009.
Lucas O, Ward S, Zaidi R, Bunkum A, Frankell A, Moore D
Nat Genet. 2024; 57(1):103-114.
PMID: 39614124
PMC: 11735394.
DOI: 10.1038/s41588-024-01989-z.
Metastasis-directed ablation of hepatocellular carcinoma with pulmonary oligometastases: a long-term multicenter study.
Zhou Q, Li R, Wu S, Zhang Y, Wang W, Zhu K
Radiol Med. 2024; 130(1):25-36.
PMID: 39531158
DOI: 10.1007/s11547-024-01907-7.
Molecular features of NSCLC patients with liver metastasis.
Zhao J, Zhong J, Chen Y, Chen Z, Yin H, He Y
Ther Adv Med Oncol. 2024; 16:17588359241275421.
PMID: 39346119
PMC: 11437564.
DOI: 10.1177/17588359241275421.
Analysis of ATP7A Expression and Ceruloplasmin Levels as Biomarkers in Patients Undergoing Neoadjuvant Chemotherapy for Advanced High-Grade Serous Ovarian Carcinoma.
Lukanovic D, Polajzer S, Matjasic M, Kobal B, cerne K
Int J Mol Sci. 2024; 25(18).
PMID: 39337685
PMC: 11432368.
DOI: 10.3390/ijms251810195.
Oncogenic microRNA-1290 and Gene as Potential Biomarker for Colorectal Carcinoma.
Naseem R, Shahid S, Shahid W, Abbas G
Technol Cancer Res Treat. 2024; 23:15330338241286283.
PMID: 39327992
PMC: 11439174.
DOI: 10.1177/15330338241286283.
Resolving tumor evolution: a phylogenetic approach.
Li L, Xie W, Zhan L, Wen S, Luo X, Xu S
J Natl Cancer Cent. 2024; 4(2):97-106.
PMID: 39282584
PMC: 11390690.
DOI: 10.1016/j.jncc.2024.03.001.
Inferring cancer type-specific patterns of metastatic spread using Metient.
Koyyalagunta D, Ganesh K, Morris Q
bioRxiv. 2024; .
PMID: 39282311
PMC: 11398359.
DOI: 10.1101/2024.07.09.602790.
Divergent iron regulatory states contribute to heterogeneity in breast cancer aggressiveness.
Leineweber W, Rowell M, Ranamukhaarachchi S, Walker A, Li Y, Villazon J
iScience. 2024; 27(9):110661.
PMID: 39262774
PMC: 11387597.
DOI: 10.1016/j.isci.2024.110661.
Chromosomal instability is associated with prognosis and efficacy of bevacizumab after resection of colorectal cancer liver metastasis.
Li W, Lan J, Zhou C, Yang R, Wang J, He J
Ann Med. 2024; 56(1):2396559.
PMID: 39247989
PMC: 11385633.
DOI: 10.1080/07853890.2024.2396559.
Tumor microenvironment dynamics in oral cancer: unveiling the role of inflammatory cytokines in a syngeneic mouse model.
Tobe-Nishimoto A, Morita Y, Nishimura J, Kitahira Y, Takayama S, Kishimoto S
Clin Exp Metastasis. 2024; 41(6):891-908.
PMID: 39126553
PMC: 11607012.
DOI: 10.1007/s10585-024-10306-1.
Mechanism insights and therapeutic intervention of tumor metastasis: latest developments and perspectives.
Shi X, Wang X, Yao W, Shi D, Shao X, Lu Z
Signal Transduct Target Ther. 2024; 9(1):192.
PMID: 39090094
PMC: 11294630.
DOI: 10.1038/s41392-024-01885-2.
Single-cell RNA-seq reveals the transcriptional program underlying tumor progression and metastasis in neuroblastoma.
Nian Z, Wang D, Wang H, Liu W, Ma Z, Yan J
Front Med. 2024; 18(4):690-707.
PMID: 39014137
DOI: 10.1007/s11684-024-1081-7.
CCL11/CCR3-dependent eosinophilia alleviates malignant pleural effusions and improves prognosis.
Xia L, Peng W, Xie G, Li F, Zhang C, Syeda M
NPJ Precis Oncol. 2024; 8(1):138.
PMID: 38951159
PMC: 11217290.
DOI: 10.1038/s41698-024-00608-8.
Patterns of Aneuploidy and Signaling Consequences in Cancer.
Zhakula-Kostadinova N, Taylor A
Cancer Res. 2024; 84(16):2575-2587.
PMID: 38924459
PMC: 11325152.
DOI: 10.1158/0008-5472.CAN-24-0169.
ScRNA-seq revealed the tumor microenvironment heterogeneity related to the occurrence and metastasis in upper urinary tract urothelial carcinoma.
Xin S, Zhang Y, Zhang Z, Li Z, Sun X, Liu X
Cancer Gene Ther. 2024; 31(8):1201-1220.
PMID: 38877164
DOI: 10.1038/s41417-024-00779-3.
Exploring the role of innate immunity in Cholangiocarcinoma: implications for prognosis, immune infiltration, and tumor metastasis.
Sun W, Ge J, Zhang L, Zhou F, Liu J
J Cancer. 2024; 15(11):3547-3565.
PMID: 38817870
PMC: 11134439.
DOI: 10.7150/jca.94194.